“The Report Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 – Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”
GBI Research’s report, “Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth”, provides a detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes therapeutic categories analysis and CMO growth in the region, and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all of the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.
Asia-Pacific is the second largest regional market for APIs by revenue in the world. The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue standing at $108,613m. Total revenue generated by the Asia-Pacific API market was $30,693m in 2011, and is expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017. This will be supported by healthy demand from the biotech and generic API sectors.
View Report At :http://www.marketresearchreports.biz/analysis/149597
Market revenue data for APIs from 2005 to 2011 and forecasts for six years to 2017.
API markets in key countries in the region, including Japan, China, South Korea and India.
API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region.
Drivers of the API market, such as the growth of generic drugs, and restraints.
Detailed historic and forecast trends and share analysis of API revenue, based on product types (synthetic and biotech APIs) in the Asia-Pacific market, and in key countries of the region.
d on customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) in the Asia-Pacific market, and in key countries of the region.
Analysis of API revenue based on therapeutic categories at a regional and key country level.
Reasons to buy
Develop business strategies with the help of specific insights on the Asia-Pacific API market.
Identify opportunities and challenges in the Asia-Pacific API market.
Invest in the growing segments of the API market.
Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Asia-Pacific API market.
Benchmark your operations and strategies against the major players in the global API market.
Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/149597
Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
3 Contract Manufacturing Organizations (CMO) 11
3.1 Process of CMO Outsourcing 11
3.2 Asia-Pacific CMO Market Drivers 12
3.2.1 Availability of Low-cost Skilled Manpower 12
3.2.2 Key Benefits of Outsourcing 13
3.3 Asia-Pacific CMO Market Revenues and Forecast to 2017 14
4 Asia-Pacific Active Pharmaceutical Ingredients Market 16
4.1 Asia-Pacific API Industry Structure 16
4.2 Asia-Pacific API Distribution Structure 17
4.3 Asia-Pacific API Market Overview 18
4.4 Asia-Pacific APIs Market Segmentation 19
4.4.1 Synthetic APIs 19
4.4.2 Biotech APIs 20
4.5 Asia-Pacific APIs Market Drivers 20
4.5.1 Growing Pharmaceutical Manufacturing Capabilities of Developing Countries Such as China and India are Attracting APIs Manufacturing from Developed Countries 20
4.5.2 Domestic Market Growth of Developing Countries in Asia-Pacific is Providing Global Pharmaceutical Industry Growth 20
4.5.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute Significantly to Asia-Pacific APIs Market Growth 20
4.5.4 The Improving Regulatory Framework in Markets of China and India is Increasing the Penetration of Branded Drugs 21
4.5.5 Patent Expiries of Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific 21
4.6 Asia-Pacific APIs Market Restraints 21
4.6.1 Increasing Patent Expiries Hamper the Growth of the Branded API Market 21
4.6.2 Highly Fragmented Market Restricts the Revenue Growth of the Asia-Pacific API Market 21
4.6.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 21
4.6.4 High Currency Fluctuations Hamper the Value Growth of the Pharmaceutical Market in the Asia-Pacific Region 22
4.7 Asia-Pacific APIs Market Revenue and Forecasts to 2017 22
4.8 Asia-Pacific Revenue Share Analysis by Product Types 24
4.9 Asia-Pacific Synthetic APIs Market 25
4.9.1 Asia-Pacific Synthetic APIs Market Drivers 25
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207